International audienceThe clear cell subtype of renal carcinoma (CCRCC) is highly vascularized and despite a slow progression rate, it is potentially a highly aggressive tumor. Although a doubling of median progression-free survival in CCRCC patients treated by targeted therapies has been observed, the fact that tumors escape after anti-VEGF treatment suggests alternative pathways. The chick chorioallantoic membrane (CAM) is a well-established model, which allows in vivo studies of tumor angiogenesis and the testing of anti-angiogenic molecules. However, only a few data exist on CCRCC grafted onto CAM. We aimed to validate herein the CAM as a suitable model for studying the development of CCRCC and the interactions with the surrounding stro...
Background: Rapid development of novel treatment options demands valid preclinical screening models ...
International audienceClear cell Renal Cell Carcinoma (ccRCC) is one of the most prevalent kidney ca...
Introduction: Advancements in cancer management and treatment are associated with strong preclinical...
Introduction: Advancements in cancer management and treatment are associated with strong preclinical...
Nasopharyngeal carcinoma (NPC) is a highly invasive and metastatic head and neck cancer. However, me...
Metastatic clear cell renal cell carcinoma (ccRCC) is the most common subtype of kidney cancer. Loca...
The chick chorioallantoic membrane (CAM), as an extraembryonic tissue layer generated by the fusion ...
Clear cell renal cell carcinoma (ccRCC) is an aggressive subtype of renal cell carcinoma accounting ...
Models of tumor angiogenesis have played a critical role in understanding the mechanisms involved in...
International audienceBACKGROUND: The chick chorio-allantoic membrane (CAM) assay is a commonly used...
Abstract Background The chick chorio-allantoic membrane (CAM) assay is a commonly used method for st...
Angiogenesis, the formation of new blood vessels, is essential for tumor growth, progression and met...
The chick embryo chorioallantoic membrane (CAM) has long been used as an in vivo assay for the study...
The chick embryo chorioallantoic membrane (CAM) has long been a favored system for the study of tumo...
Non-invasive bladder cancer cell lines (AY27) and renal cancer cell lines (RCC) are utilized in in v...
Background: Rapid development of novel treatment options demands valid preclinical screening models ...
International audienceClear cell Renal Cell Carcinoma (ccRCC) is one of the most prevalent kidney ca...
Introduction: Advancements in cancer management and treatment are associated with strong preclinical...
Introduction: Advancements in cancer management and treatment are associated with strong preclinical...
Nasopharyngeal carcinoma (NPC) is a highly invasive and metastatic head and neck cancer. However, me...
Metastatic clear cell renal cell carcinoma (ccRCC) is the most common subtype of kidney cancer. Loca...
The chick chorioallantoic membrane (CAM), as an extraembryonic tissue layer generated by the fusion ...
Clear cell renal cell carcinoma (ccRCC) is an aggressive subtype of renal cell carcinoma accounting ...
Models of tumor angiogenesis have played a critical role in understanding the mechanisms involved in...
International audienceBACKGROUND: The chick chorio-allantoic membrane (CAM) assay is a commonly used...
Abstract Background The chick chorio-allantoic membrane (CAM) assay is a commonly used method for st...
Angiogenesis, the formation of new blood vessels, is essential for tumor growth, progression and met...
The chick embryo chorioallantoic membrane (CAM) has long been used as an in vivo assay for the study...
The chick embryo chorioallantoic membrane (CAM) has long been a favored system for the study of tumo...
Non-invasive bladder cancer cell lines (AY27) and renal cancer cell lines (RCC) are utilized in in v...
Background: Rapid development of novel treatment options demands valid preclinical screening models ...
International audienceClear cell Renal Cell Carcinoma (ccRCC) is one of the most prevalent kidney ca...
Introduction: Advancements in cancer management and treatment are associated with strong preclinical...